MODERN PRINCIPLES OF CLASSIFICATION, PROGNOSIS AND TREATMENT OF PRIMARY MYELODYSPLASTIC SYNDROMES-Reference-Cited by-同舟云学术

MODERN PRINCIPLES OF CLASSIFICATION, PROGNOSIS AND TREATMENT OF PRIMARY MYELODYSPLASTIC SYNDROMES

Published:2011-03-28 Issue:1 Volume: Page:34-41
ISSN:2708-6011
Container-title:Health and Ecology Issues
language:
Short-container-title:jour

Author:

Klimkovich N. N.¹

Affiliation:

1. Belarusian Medical Academy of Post-Graduate Education

Abstract

Article is devoted myelodysplastic syndromes (MDS). It is group malignant diseases of a bone marrow in which basis the pathology hаemopoetic stem cells, leading to infringement proliferations and differentiations of hаemopoetic cells - predecessors with their change morphological and functional properties. Development of ordering MDS by variants, in particular, new classification the WHO (2008) is described. The estimation prognostic parametrs and systems is spent. Modern sights at treatment MDS with the account are presented an individualization of therapy on the basis of prognostic factors. The characteristic of new medical products and the analysis of results of application of standard therapeutic schemes in various modes and combinations is given.

Publisher

Gomel State Medical University

Reference28 articles.

1. Bennet, J. M. Proposals for the classification of the myelodysplastic syndromes / J. M.Bennet, D. Catovsky, M. T. Daniel // British journal of hematology. - 1982. - Vol. 51. - P. 189-199.

2. TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes / O. Kosmider [et al.] // Blood. - 2009. - Vol. 114, № 15. - P. 3285-3291.

3. Guidelines for the diagnosis and treatment of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia. Nordic MDS Group / L. Kjeldsen [et al.] // Blood. - 2010. - № 5. - 43 p.

4. Myelodysplastic Syndromes / A. F. List [et al.] // Hematology. - 2004. - P. 297-317.

5. Myelodysplastic syndromes/neoplasms, overview / R. D. Brunning [et al.] // In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues / Ed by S. H. Swerdlow [et al.] // Lyon: IARC. - 2008. - Vol. 2. - P. 88-93.